8-K/A

AMENDMENT TO FORM 8-K

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: October 13, 2011
Period of Report: August 5, 2011
Accession Number: 0001144204-11-057609

View Document ↗ View on SEC.gov ↗